Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Agreements relating to Assignment of TPL Seat on PDS BoD

"maybe they can make more money from slim-shady deals with DL than with share price appreciation"

That is pretty much the case here: no risk, milk it out over the lifetime of the patent and collect on $500k a year....

Share
New Message
Please login to post a reply